Answers are grounded in this paper and cite their sources.
Mechanistic studies suggest that proprotein convertase subtilisin/kexin type 9 inhibitors can modulate inflammation.
No takes yet. Share an insight, caveat, or question.
Rosenson et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: